"Show me the money": a fair criticism of economic studies on inhaled bronchodilators for COPD
<p>Abstract</p> <p>Chronic obstructive pulmonary disease (COPD) represents a significant burden for healthcare systems that is expected to grow further in the future. Inhaled long-acting bronchodilators, including tiotropium, represent the cornerstone of management of COPD patients...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2010-09-01
|
Series: | BMC Pulmonary Medicine |
Online Access: | http://www.biomedcentral.com/1471-2466/10/48 |